As a result, the Nrf2/HO-1 signaling axis mainly plays an anti-inflammatory role in pneumonia, and the induction of HO-1 expression may be a possible therapy in its clinical treatment. Here, HMOX1 is linked to susceptibility to pneumonia measurement.